EnlitenAI is an AI-driven digital health startup dedicated to enhancing the management and treatment of neurological conditions, with a specific focus on seizures and epilepsy. The company offers a data-driven, personalized seizure management platform designed to provide better outcomes for patients. EnlitenAI's mission is rooted in the founder's personal experience with drug-resistant epilepsy, aiming to make a significant impact on the lives of those affected by this condition.
EnlitenAI has made notable strides in the digital health sector, leveraging advanced AI technology to address complex neurological issues. The company's innovative approach has garnered attention and support from various stakeholders in the healthcare industry. By focusing on personalized care and utilizing cutting-edge data analytics, EnlitenAI is poised to transform the way neurological conditions are managed, offering hope and improved quality of life for millions of patients worldwide.
